Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Pulmonology · Bronchiolitis Obliterans

Living with Bronchiolitis Obliterans: Monitoring and Daily Life

At a Glance

Because non-transplant bronchiolitis obliterans causes permanent narrowing and scarring of the small airways, care focuses on monitoring lung function, protecting against infections and irritants, improving daily activity, and recognizing progression early.

Living with non-transplant bronchiolitis obliterans is a journey of adaptation. Because the condition involves permanent physical changes to your small airways, the focus of daily life shifts from “curing” the disease to protecting your lungs and maintaining your quality of life [1]. While the diagnosis can be daunting, many patients remain stable for years, especially when triggers are removed and proactive care is prioritized [2][3]. However, prognosis remains uncertain, and your team will monitor your individual trajectory.

Monitoring Your Progress

Because changes in this condition can be slow, structured monitoring is the best way to ensure your treatment plan is working. There is no “one-size-fits-all” schedule, but your doctor will likely use a combination of the following:

  • Pulmonary Function Tests (PFTs): These are the most critical tool for tracking your stability. Your care team will look for a consistent decline in your FEV1 (the amount of air you can blow out in one second). While results can vary slightly from day to day, a significant downward trend over several tests may indicate disease progression [4][5].
  • Oxygen Saturation: You may be asked to perform a six-minute walk test or use a pulse oximeter to check your oxygen levels during activity. A new need for supplemental oxygen or a drop in your saturation levels during movement is a key signal that your condition may be changing [6][7]. If using home pulse oximetry, remember that readings can be inaccurate and do not measure carbon dioxide. Never change your oxygen flow based on a home reading without explicit instructions, and seek urgent care for severe symptoms regardless of the number displayed.
  • Imaging (HRCT): You do not usually need a CT scan at every visit. Instead, a High-Resolution CT is typically repeated only if your symptoms significantly worsen or your PFTs show a new decline [4][8].

The Power of Pulmonary Rehabilitation

Pulmonary rehabilitation is a supervised program that combines exercise, education, and support. It is one of the most effective ways to improve your daily function.

  • Physical Benefits: In studies (including those of broader chronic lung diseases and transplant populations), structured exercise programs—including high-intensity interval training (HIIT) and strength training—have been shown to improve oxygen uptake, leg strength, and overall exercise capacity [9][10]. High-intensity regimens are not a safe self-directed prescription; they must be carefully tailored by professionals based on your specific oxygenation and cardiovascular status.
  • Breathing Strategies: Rehabilitation helps you learn techniques like pursed-lip breathing. While this does not reverse airway collapse, it can help reduce the feeling of breathlessness during activity [7][11].
  • Energy Conservation: You will learn how to pace your daily chores and activities to avoid “crashing” or becoming over-exhausted [7].

Protecting Your Lungs Every Day

Since your airways are already narrowed, they are more sensitive to new injuries. Preventing further “insults” to your lungs is a cornerstone of management.

  • Infection Prevention: Viral and bacterial infections can cause “flares” that lead to further scarring. Staying up to date on vaccines is essential. This generally includes annual influenza and COVID-19, as well as pneumococcal and RSV vaccination based on age, risk, and current medical guidance [12][13]. While vaccines lower your risk of acute flares, they cannot guarantee the prevention of all chronic progression.
  • Environmental Control: If your condition was caused by an exposure, you must remain vigilant about avoiding that trigger. This includes staying away from wood smoke, strong chemical cleaning products, and vaping [14][15].
  • Smoking Cessation: If you smoke, quitting is the single most important step you can take to prevent rapid decline. Even second-hand smoke can irritate your sensitive small airways [16].

Navigating the Psychological Impact

Living with a rare, chronic lung disease carries a heavy emotional weight. Many patients experience anxiety or depression related to their shortness of breath or the uncertainty of their prognosis [17][18].

  • Validation: It is normal to feel frustrated when others don’t understand your condition because it is rare. Seeking out support groups (even online) for “small airway disease” or “bronchiolitis” can provide a sense of community [16][19].
  • Mental Health Support: Specialized respiratory programs often include nurse-led counseling and mental health screenings. Addressing anxiety and depression is not just about “feeling better”—it can actually improve your physical ability to manage your breathing and stay active [7][20].

Signs of Progression

While many cases are stable, you and your caregiver should watch for these signs that your condition may be advancing. Note that an acute, sudden change (like fever or coughing blood) requires a different urgent plan compared to these chronic signs of progression:

  1. Increased Dyspnea: Finding that you are short of breath at a lower level of activity than before over a persistent period of months [21][22].
  2. Increased Oxygen Needs: Requiring more liters of oxygen per minute, or needing oxygen for the first time while resting [22].
  3. Frequent Hospitalizations: A pattern of repeated lung infections or “flare-ups” that require medical intervention [23].
  4. Weight Loss: Unintentional weight loss can be a sign that your body is using too much energy just to breathe [24]. These trends should prompt a routine appointment assessment.

Common questions in this guide

How is non-transplant bronchiolitis obliterans monitored over time?
Your care team will usually track breathing tests, especially FEV1, which measures how much air you can blow out in one second. They may also check oxygen levels during activity with a six-minute walk or pulse oximeter. A high-resolution CT scan is generally reserved for significant symptom worsening or a new decline in breathing tests.
Can pulmonary rehabilitation improve daily life with bronchiolitis obliterans?
Yes. A supervised program combining exercise, education, breathing strategies, and pacing can improve strength and the ability to do daily activities. It does not reverse permanent airway scarring, and intense exercise should be prescribed and monitored by professionals.
What can I do every day to protect my lungs?
Stay current on vaccines recommended for you, avoid smoke, vaping, wood smoke, and strong chemical fumes, and stop smoking if you smoke. Use prescribed oxygen and breathing techniques as directed. These steps can reduce additional lung injury and infections but cannot guarantee that the condition will not progress.
What signs suggest bronchiolitis obliterans is getting worse?
Over months, watch for breathlessness with less activity, new or increased oxygen needs, repeated infections or hospital stays, and unintentional weight loss. These changes should prompt a review with your care team. Sudden severe symptoms, fever, or coughing blood need urgent medical guidance rather than waiting for a routine appointment.
Can non-transplant bronchiolitis obliterans remain stable?
Many people remain stable for years, especially after triggers are removed and ongoing care is followed. The outlook varies, however, so regular breathing tests and review of symptoms are important even when you feel unchanged.
Should I change my oxygen flow based on a home pulse oximeter reading?
No. Home pulse oximeters can be inaccurate and do not measure carbon dioxide, so you should not change oxygen flow unless your care team has given you specific instructions. Seek urgent care for severe symptoms regardless of the number shown.
How can I cope with anxiety or low mood related to this lung condition?
Anxiety and depression can occur when breathlessness and uncertainty affect daily life. Ask about counseling, mental health screening, respiratory support programs, or peer support groups; addressing emotional health may also help you stay active and manage breathing.

Get notified when new evidence is published on Non-transplant-related bronchiolitis obliterans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    Obliterative Bronchiolitis.

    Aguilar PR, Michelson AP, Isakow W

    Transplantation 2016; (100(2)):272-83 doi:10.1097/TP.0000000000000892.

    PMID: 26335918
  2. 2

    Severe cryptogenic bronchiolitis: Case report.

    Ramírez LE, Amézquita MA, Morales EI, et al.

    Respiratory medicine case reports 2023; (45()):101910 doi:10.1016/j.rmcr.2023.101910.

    PMID: 37663528
  3. 3

    Sporadic Obliterative Bronchiolitis: Case Series and Systematic Review of the Literature.

    Callahan SJ, Vranic A, Flors L, et al.

    Mayo Clinic proceedings. Innovations, quality & outcomes 2019; (3(1)):86-93 doi:10.1016/j.mayocpiqo.2018.10.003.

    PMID: 30899912
  4. 4

    Overview and Challenges of Bronchiolar Disorders.

    Swaminathan AC, Carney JM, Tailor TD, Palmer SM

    Annals of the American Thoracic Society 2020; (17(3)):253-263 doi:10.1513/AnnalsATS.201907-569CME.

    PMID: 31860801
  5. 5

    Longitudinal Assessment of Pulmonary Function and Bronchodilator Response in Pediatric Patients With Post-infectious Bronchiolitis Obliterans.

    Yu X, Wei J, Li Y, et al.

    Frontiers in pediatrics 2021; (9()):674310 doi:10.3389/fped.2021.674310.

    PMID: 34095034
  6. 6

    EXERCISE CAPACITY IN CHILDREN AND ADOLESCENTS WITH POST-INFECTIOUS BRONCHIOLITIS OBLITERANS: A SYSTEMATIC REVIEW.

    Rodrigues CMB, Schiwe D, Campos NE, et al.

    Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo 2019; (37(2)):234-240 doi:10.1590/1984-0462/;2019;37;2;00017.

    PMID: 30892545
  7. 7

    Three-year follow-up of individualized respiratory rehabilitation therapy for post-infectious bronchiolitis obliterans: a pediatric case report.

    Peng L, Kuai Z, Yang T, et al.

    Journal of pediatric nursing 2026; doi:10.1016/j.pedn.2026.09.038.

    PMID: 42838806
  8. 8

    Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors.

    Myrdal OH, Aaløkken TM, Diep PP, et al.

    Respiration; international review of thoracic diseases 2022; (101(6)):544-552 doi:10.1159/000520824.

    PMID: 34937032
  9. 9

    Home-based, remotely supervised, high-intensity interval training and cardiorespiratory fitness in children and adolescents with post-infectious bronchiolitis obliterans: a randomised controlled trial.

    Salazar-Pérez F, Sanz-Santiago V, de Mir-Messa I, et al.

    The European respiratory journal 2026; (68(4)) doi:10.1183/13993003.00265-2026.

    PMID: 42242758
  10. 10

    Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans.

    Calabrese C, Corcione N, Rea G, et al.

    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2016; (42(3)):228-31.

    PMID: 27383939
  11. 11

    RESPIRATORY MUSCLE IMPAIRMENT EVALUATED WITH MEP/MIP RATIO IN CHILDREN AND ADOLESCENTS WITH CHRONIC RESPIRATORY DISEASE.

    Rodríguez-Núñez I, Torres G, Luarte-Martinez S, et al.

    Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo 2020; (39()):e2019414 doi:10.1590/1984-0462/2021/39/2019414.

    PMID: 33331560
  12. 12

    [A case of bronchiolitis obliterans secondary to human metapneumovirus bronchiolitis].

    Yeşilbaş O, Şevketoğlu E, Kıhtır HS, et al.

    Mikrobiyoloji bulteni 2016; (50(4)):606-612 doi:10.5578/mb.32195.

    PMID: 28124966
  13. 13

    Post-infectious bronchiolitis obliterans.

    Colom AJ, Teper AM

    Pediatric pulmonology 2019; (54(2)):212-219 doi:10.1002/ppul.24221.

    PMID: 30548423
  14. 14

    Update on flavoring-induced lung disease.

    Holden VK, Hines SE

    Current opinion in pulmonary medicine 2016; (22(2)):158-64 doi:10.1097/MCP.0000000000000250.

    PMID: 26761629
  15. 15

    Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youth.

    Landman ST, Dhaliwal I, Mackenzie CA, et al.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2019; (191(48)):E1321-E1331 doi:10.1503/cmaj.191402.

    PMID: 31753841
  16. 16

    Occupational exposures in constrictive bronchiolitis.

    Nena E, Steiropoulos P, Voulgaris A, et al.

    Pathology, research and practice 2020; (216(9)):153069 doi:10.1016/j.prp.2020.153069.

    PMID: 32825942
  17. 17

    Health-related quality of life in patients with bronchiolitis obliterans.

    Atag E, Bas Ikizoglu N, Ergenekon P, et al.

    Pediatric pulmonology 2020; (55(9)):2361-2367 doi:10.1002/ppul.24896.

    PMID: 32515559
  18. 18

    Health-related quality of life in post-infectious bronchiolitis obliterans: agreement between children and their proxy.

    Sarria EE, Mundstock E, Mocelin HT, et al.

    Jornal de pediatria 2019; (95(5)):614-618 doi:10.1016/j.jped.2018.05.014.

    PMID: 31327498
  19. 19

    Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.

    DerHovanessian A, Wallace WD, Lynch JP, et al.

    Seminars in respiratory and critical care medicine 2018; (39(2)):155-171 doi:10.1055/s-0037-1618567.

    PMID: 29579768
  20. 20

    Health-related quality of life in patients with bronchiolitis obliterans.

    Sarria EE, Mundstock E, Machado DG, et al.

    Jornal de pediatria 2018; (94(4)):374-379 doi:10.1016/j.jped.2017.07.021.

    PMID: 29172039
  21. 21

    Environmental and occupational bronchiolitis obliterans: new reality.

    Gutor SS, Miller RF, Blackwell TS, Polosukhin VV

    EBioMedicine 2023; (95()):104760 doi:10.1016/j.ebiom.2023.104760.

    PMID: 37598462
  22. 22

    Unexpected Complication of R-CHOP Chemotherapy: Rapidly Progressive Bronchiolitis Obliterans Syndrome.

    Nozaki K, Ezoe S, Hamaguchi M, et al.

    European journal of case reports in internal medicine 2019; (6(11)):001266 doi:10.12890/2019_001266.

    PMID: 31890707
  23. 23

    Risk factors for bronchiolitis obliterans in children with community-acquired pneumonia and analysis of CT findings and clinical manifestations of pneumonia after the diagnosis of bronchiolitis obliterans.

    Hou J, Sun R, Zhang X, et al.

    Annals of medicine 2025; (57(1)):2578730 doi:10.1080/07853890.2025.2578730.

    PMID: 41163588
  24. 24

    Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease.

    Turner J, He Q, Baker K, et al.

    Transplantation and cellular therapy 2021; (27(7)):616.e1-616.e6 doi:10.1016/j.jtct.2021.03.024.

    PMID: 33781975

This page is for informational purposes only and does not constitute medical advice. Your pulmonology team should interpret your breathing tests, oxygen readings, and symptoms and advise you about activity, vaccines, and urgent care.

Guide contents Non-transplant-related bronchiolitis obliterans
Research & Literature
04 Treatment Strategies